絞り込み

16754

広告

大分空港が宇宙港に 空から人工衛星打ち上げめざす (朝日新聞)

大分空港の宇宙港としての活用を発表する広瀬勝貞・大分県知事とネットを通じて記者会見に参加した山崎直子さん=2020年4月3日午前11時1分、大分県庁、寿柳聡撮影...

  1. 新型コロナウイルス感染症の現在の状況につ...
  2. 8日夜はスーパームーン、最も遠い時より3...
  3. 論文の掲載、時に1本50万円必要 研究者...
  4. 集中治療 早期に医療体制崩壊のおそれ 学...

ニュース一覧

Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.

著者 Hennis MR , Marvin MA , Taylor CM , Goldberg MS
Neurobiol Dis.2013 Sep 25 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX 75390.

スターを付ける スターを付ける     (76view , 0users)

Full Text Sources

Medical

Miscellaneous

Molecular Biology Databases

Parkinson's disease (PD) is the second most common neurodegenerative disorder behind Alzheimer's disease. There are currently no therapies proven to halt or slow the progressive neuronal cell loss in PD. A better understanding of the molecular and cellular causes of PD is needed to develop disease-modifying therapies. PD is an age-dependent disease that causes the progressive death of dopamine-producing neurons in the brain. Loss of substantia nigra dopaminergic neurons results in locomotor symptoms such as slowness of movement, tremor, rigidity and postural instability. Abnormalities in other neurotransmitters, such as serotonin, may also be involved in both the motor and non-motor symptoms of PD. Most cases of PD are sporadic but many families show a Mendelian pattern of inherited parkinsonism and causative mutations have been identified in genes such as Parkin, DJ-1, PINK1, alpha-synuclein and Leucine Rich Repeat Kinase 2 (LRRK2). Although the definitive causes of idiopathic PD remain uncertain, the activity of the antioxidant enzyme glutathione peroxidase 1 (Gpx1) is reduced in PD brains and has been shown to be a key determinant of vulnerability to dopaminergic neuron loss in PD animal models. Furthermore, Gpx1 activity decreases with age in human substantia nigra but not rodent substantia nigra. Therefore, we crossed mice deficient for both Parkin and DJ-1 with mice deficient for Gpx1 to test the hypothesis that loss-of-function mutations in Parkin and DJ-1 cause PD by increasing vulnerability to Gpx1 deficiency. Surprisingly, mice lacking Parkin, DJ-1 and Gpx1 have increased striatal dopamine levels in the absence of nigral cell loss compared to wild-type, Gpx1(-/-), and Parkin(-/-)DJ-1(-/-) mutant mice. Additionally, Parkin(-/-)DJ-1(-/-) mice exhibit improved rotarod performance and have increased serotonin in the striatum and hippocampus. Stereological analysis indicated that the increased serotonin levels were not due to increased serotonergic projections. The results of our behavioral, neurochemical and immunohistochemical analyses reveal that PD-linked mutations in Parkin and DJ-1 cause dysregulation of neurotransmitter systems beyond the nigrostriatal dopaminergic circuit and that loss-of-function mutations in Parkin and DJ-1 lead to adaptive changes in dopamine and serotonin especially in the context of Gpx1 deficiency.
PMID: 24075852 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード